CORTICOSTEROID-FREE REMISSION IN ANTI-TNF FAILED CROHN’S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB AS SECOND-LINE BIOLOGIC THERAPY: A REAL WORLD DATA REVIEW

Christian Agboton ¹ Dirk Lindner ²
¹ Takeda, Cambridge, United States
² Takeda, Zurich, Switzerland

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing